Successful Treatment of Cutaneous Protothecosis Due to Prototheca wickerhamii with Terbinafine
DOI: https://doi.org/10.2147/ccid.s453620
2024-04-25
Clinical Cosmetic and Investigational Dermatology
Abstract:Yue Chen, 1, &ast Aili Gao, 1, &ast Yanan Ke, 1 Xin Zhou, 1 Li Lin, 2 Sha Lu, 2 Yumei Liu 1 1 Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, 510095, People's Republic of China; 2 Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yumei Liu, Director of Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, People's Republic of China, Tel/Fax +86- 20-83593472, Email Protothecosis, an infrequent human infection, is caused by achlorophyllic algae belonging to the genus Prototheca, particularly Prototheca wickerhamii. The skin stands as the most commonly affected organ. This report documents a case involving an 82-year-old male with Protothecosis. Histopathological analysis revealed granulomatous inflammation in the dermis, exhibiting necrotic features and hosting numerous non-budding spherical organisms. These organisms were positively stained using methenamine silver and periodic acid–Schiff stains, confirming identification as P. wickerhamii after validation through tissue culture and sequencing procedures. Initially, the patient received oral itraconazole at a dosage of 200 mg daily, accompanied by topical 1% naftifine-0.25% ketoconazole cream for a duration of 4 weeks, resulting in significant improvement. Subsequently, due to gastrointestinal discomfort presumably linked to itraconazole, terbinafine was administered. Over a span of 3 months, the patient received oral terbinafine at a dosage of 250 mg/day alongside the application of topical 1% naftifine-0.25% ketoconazole cream, leading to complete healing of the skin lesion, leaving behind a fibrotic scar. Keywords: protothecosis, Prototheca wickerhamii , terbinafine Protothecosis represents a rare opportunistic human infection caused by the genus Prototheca , consisting of achlorophyllic algae widely present in nature. 1,2 Prototheca species, including P. ciferrii (previously known as P. zopfii genotype 1), P. bovis (previously known as P. zopfii genotype 2), P. wickerhamii, P. blaschkeae, P. cutis , and P. miyajii3 , can cause infections in both humans and animals. While Prototheca species are commonly isolated from domestic animals, such as cattle, dogs, and cats, cases have also been reported in goats, horses, and other nondomestic animals, with P. wickerhamii being the primary cause of human infections. 3–5 Prototheca algae have been found to be isolated from terrestrial sources, including soil, mud, and stream sediments, in regions characterized by a high organic matter content and moisture level. 6 The prevailing belief is that Prototheca species infect humans either through direct contact with exposed areas or via traumatic inoculation of materials contaminated with the algae. 1,7–10 This infection typically manifests in three primary forms: intra-cutaneous to subcutaneous nodules and plaques, olecranon bursitis, and systemic (disseminated) disease. 11 Notably, the skin emerges as the organ most frequently affected. Cutaneous infections commonly arise in immunocompetent patients, while disseminated infections predominantly impact immunocompromised individuals. 1,11,12 Clinical management lacks a standardized protocol due to varying treatment efficacies. 13,14 In this context, we present a case of cutaneous protothecosis effectively cured through a three-month course of terbinafine treatment. An 82-year-old man presented at the hospital with a 4-month history of skin lesions. Preceding these lesions, he experienced a stab wound on the dorsal side of his left forearm from firewood, promptly cleaned and dressed with an antiseptic iodine solution. Subsequently, he noticed moderate itching and redness in the same area a few days later. Initially diagnosed with eczema, he received symptomatic treatment involving a potent corticosteroid cream containing clobetasol and antihistamine, which failed to control the rash. Instead, the affected area rapidly expanded to the flexor aspect of the left arm and the back of the left hand, accompanied by itching and pain. Concurrently, he received oral cefdinir, compound glycyrrhizin, and loratadine. The patient denied any prior medical history or conditions except hypertension. Dermatological examination revealed diffuse infiltrated erythematous and indurated plaques covering the dorsal side of the left forearm, the back of the left hand, and the flexor aspect of the left arm. Within the affected area, numerous -Abstract Truncated-
dermatology